Federal Official Gazette
No new relevant publications were identified.
ANS news
ANS holds webinar on economic and financial data for the first half of 2026
ANS has updated the announcement of the webinar, which will be held tomorrow, Sep 16, at 2 p.m. The event will present the health plan operators’ economic and financial results for the first half of 2026. On the same date, the Agency’s dashboard will be updated with indicators on results, revenues, healthcare expenses, payment methods, per capita data and the relationship between equity and operators’ results.
Open public consultations
- CP 176. Subject: preliminary recommendations against incorporating the technology covered by UAT No. 184 – Molecular DNA analysis; search for microdeletions by FISH (Fluorescent In Situ Hybridization); microsatellite instability (MSI), detection by PCR, paraffin block, DUT SUBITEM – 110.39 – Syndrome of chromosomal abnormalities not clinically recognizable (array). Deadline: September 21 to October 10, 2026.
- CP 177. Subject: preliminary recommendations against incorporating the technologies covered by UAT No. 205 – Implantation of a device for cardiac contractility modulation and UAT No. 209 – 21-gene test for genomic expression profiling of breast tumors. Deadline: September 9 to 28, 2026.
Scheduled public hearings
- AP 69. Subject: proposals to include the following technologies in the List of Health Procedures and Events (Rol):
Implantation of a device for cardiac contractility modulation, for the treatment of patients with symptomatic chronic heart failure (NYHA III–IV), refractory to optimized pharmacological treatment, with an ejection fraction between 25% and 45%, QRS complex <130 ms, and without indication for cardiac resynchronization therapy; and
21-gene test for genomic expression profiling of breast tumors, to support therapeutic decision-making for patients with early-stage breast cancer (stages I, II and IIIA), hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), and node-negative disease or node-positive disease, with involvement of one to three lymph nodes.
Date: Sep 16, from 9 a.m. to 12 p.m. To take part in Public Hearing 69, registration is required by 5 p.m. on Sep 15, on the ANS portal. The recording will be available on the Agency’s website.
Open public calls for input
There are no open public calls for input.
Open public calls
There are no open public calls or targeted social participation processes.
Other news
No new relevant publications were identified.
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.